Drugs / mRNA tumor vaccines
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06156267 | Jan 2024 → Apr 2026 overdue | pancreatic adenocarcinoma | Fudan University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA tumor vaccines | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06156267 ↗ |
| Modality | Messenger RNA (mRNA) | “neoantigen personalized mRNA vaccines” NCT06156267 ↗ |